Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

anandamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
anandamide
Unique ID
C078814
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C078814
Entry Term(s)
5,8,11,14-eicosatetraenamide, N-(2-hydroxyethyl)-
5,8,11,14-eicosatetraenoylethanolamide
N-(2-hydroxyethyl)arachidonamide
N-arachidonoyl-2-hydroxyethylamide
N-arachidonoylethanolamine
anandamide (20.4,n-6)
arachidonoyl ethanolamide
arachidonoylethanolamide
arachidonylethanolamide
n-arachidonoylethanolamide
Pharm Action
Calcium Channel Blockers
Cannabinoid Receptor Agonists
Registry Numbers
UR5G69TJKH
Related Numbers
94421-68-8
CAS Type 1 Name
5,8,11,14-Eicosatetraenamide, N-(2-hydroxyethyl)-, (all-Z)-
Previous Indexing
*AMIDES (93-94)
*ARACHIDONIC ACIDS (2011-2012)
*FATTY ACIDS, UNSATURATED (93-94)
Heading Mapped to
*Arachidonic Acids
*Polyunsaturated Alkamides
*Endocannabinoids
Frequency
2514
Source
Science 1992 Dec 18;258(5090):1882-4; Bioanalysis. 2011 Jan;3(2):181-96
Indexing Information
Receptor, Cannabinoid, CB2
Date of Entry
1993/01/22
Revision Date
2020/12/03
anandamide Preferred
N-arachidonoylethanolamine Broader
page delivered in 0.02s